Publication Name	World Journal of Hepatology
Manuscript ID	4918
Country	Greece

Received	2013-08-01 11:36
Peer-Review Started	2013-08-02 01:24
To Make the First Decision	2013-08-08 11:17
Return for Revision	2013-08-19 20:45
Revised	2013-09-03 18:50
Second Decision	2013-10-16 11:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-10-16 12:21
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-10-23 18:32
Publish the Manuscript Online	2013-10-25 08:47

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome
Manuscript Source	Invited Manuscript
All Author List	Eirini I Rigopoulou, Kalliopi Zachou, Nikolaos K Gatselis, Georgia Papadamou, George K Koukoulis and George N Dalekos
Funding Agency and Grant Number	Funding Agency Grant Number Research Committee of the University of Thessaly (in part) 2466
Corresponding Author	George N Dalekos, MD, PhD, Professor, Head, Department of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Biopolis, 41110 Larissa, Greece. dalekos@med.uth.gr
Key Words	Antimitochindrial antibodies; Autoimmune liver disease; Hepatitis B virus; Hepatitis C virus; Primary biliary cirrhosis.
Core Tip	In hepatitis B virus (HBV) and hepatitis C virus (HCV) patients the possibility of concomitant primary biliary cirrhosis (PBC), is often very difficult to recognize and therefore, a significant delay in PBC diagnosis in this specific group of patients is usual. In this report, we clearly show that almost 1% of our HBV and HCV cohort had also PBC which had been misdiagnosed or underestimated for many years. The latter could be the reason of unfavorable outcome observed in our patients and in particular, among HCV/PBC patients. Therefore, the existence of cholestasis should prompt physicians to sick for antimitochondrial antibody with various sensitive techniques irrespective of the presence of other liver diseases.
Publish Date	2013-10-25 08:47
Citation	Rigopoulou EI, Zachou K, Gatselis NK, Papadamou G, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome. World J Hepatol 2013; 5(10): 577-583
URL	http://www.wjgnet.com/1948-5182/full/v5/i10/577.htm
DOI	http://dx.doi.org/10.4254/wjh.v5.i10.577

Full Article (PDF)	WJH-5-577.pdf
Manuscript File	4918-Review.doc
Answering Reviewers	4918-Answering reviewers.pdf
Copyright License Agreement	4918-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4918-Language certificate.pdf
Peer-review Report	4918-Peer reviewer(s).pdf
Scientific Editor Work List	4918-Scientific editor work list.doc